Menu

Topical Vitamin E Ovules for the Treatment of Hemorrhoids

Status and phase

Unknown
Phase 3

Conditions

Bleeding Anal
Stings
Pain

Treatments

Drug: Prednisolone ointment
Drug: Vitamin E ovules

Study type

Interventional

Funder types

Other

Identifiers

NCT04362384
Garcilaso 2020/2

Details and patient eligibility

About

Patients with hemorrohoids grade II and III were included. Patients were randomized into 2 groups:

  • Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus
  • Control group: Patients will receive a treatment with corticoid ointment, with endoanal application

Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment.

Full description

Patients with hemorrohoids grade II and III were included.

Patients were randomized into 2 groups:

  • Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus. 1 ovule must be inserted daily during 14 days.
  • Control group: Patients will receive a treatment with prednisolone ointment, with endoanal application 3 times per day during 14 days.

Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment. Quantification of pain will be performed following a visual analogic scale ranging from 0 (absence of symptoms) to 100 (unbearable symptoms).

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Grade II and III hemorrhoids

Exclusion criteria

  • Grade I or IV hemorrhoids
  • Patients with previous anal surgeries
  • Patients having received previous pharmacological treatments for hemorrhoids

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

Vitamin E ovules
Experimental group
Description:
Endoanal Vitamin E ovules will be prescriped during 14 days
Treatment:
Drug: Vitamin E ovules
Prednisolone ointment
Active Comparator group
Description:
Endoanal Prednisolone ointment will be prescriped during 14 days
Treatment:
Drug: Prednisolone ointment

Trial contacts and locations

0

There are currently no registered sites for this trial.

Central trial contact

Jaime Ruiz-Tovar; Carolina LLavero Garrido

Timeline

Last updated: Apr 24, 2020

Start date

May 01, 2020 • 4 years ago

End date

Oct 30, 2020 • 4 years ago

Today

Apr 05, 2025

Sponsor of this trial

Data sourced from clinicaltrials.gov